Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced that its collaboration partner, Japan Tobacco, Inc. (JT) and its subsidiary…
DUBLIN–(BUSINESS WIRE)–The “Global Hyperphosphatemia Drugs Market 2019-2027” report has been added to ResearchAndMarkets.com’s offering. After a detailed analysis, this research…
DUBLIN–(BUSINESS WIRE)–The “Alcoholic Hepatitis Treatment Market by Type and Geography – Global Forecast and Analysis 2019-2023” report has been added…
Top 20 medical device company selects Vault CDMS for greater agility in clinical trial management PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva Systems (NYSE:VEEV)…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX: ASP, OTCQB: ASPCF) (“Acerus” or the “Company”) announced today an update relative to the Company’s…
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has submitted a Biologics License Application (BLA) to the U.S.…
HYDERABAD, India–(BUSINESS WIRE)–#ContractResearchandDevelopment–GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of…
Data Include Week 48 Results from Phase 2B Study Evaluating MK-8591 in Combination with Doravirine KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE:…
‒ Plan expected to reduce costs by approximately $50 million annually ‒ ‒ Reduces Full Year 2019 Adjusted EBITDA Guidance…
LONDON–(BUSINESS WIRE)–#Biotechnology–Vendors in the cancer biologics market have significantly increased investments for the development of cancer treating biologic molecules. Consequently,…